Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
FAM90A8 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for FAM90A8, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
FAM90A7 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for FAM90A7, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
FAM90A5 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for FAM90A5, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
FAM90A3 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for FAM90A3, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
FAM90A1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for FAM90A1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
FAM89B Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for FAM89B, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
FAM89A Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for FAM89A, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
FAM86B2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for FAM86B2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
FAM86B1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for FAM86B1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
FAM81B Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for FAM81B, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
FAM81A Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for FAM81A, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
FAM78B Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for FAM78B, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.